Cargando…

A Review of Danshen Combined with Clopidogrel in the Treatment of Coronary Heart Disease

OBJECTIVE: Danshen, the root of Salvia miltiorrhiza Bunge, is a traditional herbal medicine in China, which has been used to treat irregular menstruation, cold hernia, and abdominal pain for thousands of years. Danshen is frequently used in combination with drugs to treat cardiovascular diseases. Cl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhaojian, Wang, Yu, Tan, Wangxiao, Wang, Siwei, Liu, Jinghua, Liu, Xiao, Wang, Xiaoying, Gao, Xiumei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399523/ https://www.ncbi.nlm.nih.gov/pubmed/30911318 http://dx.doi.org/10.1155/2019/2721413

Ejemplares similares

The Clinical Pharmacokinetics and Pharmacodynamics of Warfarin When Combined with Compound Danshen: A Case Study for Combined Treatment of Coronary Heart Diseases with Atrial Fibrillation
por: Lv, Chunxiao, et al.
Publicado: (2017)

Improvement of Endothelial Dysfunction of Berberine in Atherosclerotic Mice and Mechanism Exploring through TMT-Based Proteomics
por: Tan, Wangxiao, et al.
Publicado: (2020)

Synergistic Effects of Clopidogrel and Fufang Danshen Dripping Pills by Modulation of the Metabolism Target and Pharmacokinetics
por: Ma, Shitang, et al.
Publicado: (2014)

Danshen (Salvia miltiorrhiza) Compounds Improve the Biochemical Indices of the Patients with Coronary Heart Disease
por: Liu, Boyan, et al.
Publicado: (2016)

Immunoregulation of Shenqi Fuzheng Injection Combined with Chemotherapy in Cancer Patients: A Systematic Review and Meta-Analysis
por: Yang, Yang, et al.
Publicado: (2017)

The Efficacy and Safety of Compound Danshen Dripping Pill Combined with Percutaneous Coronary Intervention for Coronary Heart Disease
por: Li, Cailan, et al.
Publicado: (2020)

Danshen decoction in the treatment of heart failure: A systematic review and meta-analysis protocol of randomized controlled trials
por: Liu, Mengnan, et al.
Publicado: (2022)

Efficacy and safety of clopidogrel only vs. clopidogrel added proton pump inhibitors in the treatment of patients with coronary heart disease after percutaneous coronary intervention: A systematic review and meta-analysis
por: Pang, Jun, et al.
Publicado: (2019)

Mechanism of tanshinones and phenolic acids from Danshen in the treatment of coronary heart disease based on co-expression network
por: Wu, Dongxue, et al.
Publicado: (2020)

Effect of various Danshen injections on patients with coronary heart disease after percutaneous coronary intervention: A protocol for a systematic review and network meta-analysis
por: Zhu, Zehao, et al.
Publicado: (2018)

Compound Danshen dripping pills in treating with coronary heart disease: A protocol for systematic review and meta-analysis
por: Sun, Ling, et al.
Publicado: (2022)

Evaluation of the anti-inflammatory and antioxidant pharmcodynamic compoents of naoxintong capsules as a basis of broad spectrum effects
por: Lv, Bin, et al.
Publicado: (2021)

Effect of Shenmai injection on preventing the development of nitroglycerin-induced tolerance in rats
por: Zhou, Qian, et al.
Publicado: (2017)

Effects of Dual-Dose Clopidogrel, Clopidogrel Combined with Tongxinluo Capsule, and Ticagrelor on Patients with Coronary Heart Disease and CYP2C19*2 Gene Mutation After Percutaneous Coronary Interventions (PCI)
por: Chen, Shuxia, et al.
Publicado: (2017)

Aspirin in combination with clopidogrel in the treatment of acute myocardial infarction patients undergoing percutaneous coronary intervention
por: Zhang, Xiaoyan, et al.
Publicado: (2019)

An Examination of Clopidogrel in the Treatment of Coronary Microvascular Disease
por: Iskandar, Nicholas P, et al.
Publicado: (2022)

Compound Danshen Dripping Pill Pretreatment to Prevent Contrast-Induced Nephropathy in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Yang, Rong, et al.
Publicado: (2014)

Dose-Effect Relationship of Chitosan and Danshen Combined Injection for Fallopian Tube Recanalization
por: Huang, Chen, et al.
Publicado: (2022)

Exploring the Mechanism of Danshen against Myelofibrosis by Network Pharmacology and Molecular Docking
por: Li, Jie, et al.
Publicado: (2018)

Danshen enhanced the estrogenic effects of Qing E formula in ovariectomized rats
por: Zhang, Jian-mei, et al.
Publicado: (2016)

Comparison of ticagrelor and clopidogrel in the treatment of patients with coronary heart disease carrying CYP2C19 loss of function allele
por: Qian, Wenwen, et al.
Publicado: (2022)

Evaluation of Herb–Drug Interaction Between Danshen and Rivaroxaban in Rat and Human Liver Microsomes
por: Wang, Xu, et al.
Publicado: (2022)

Mechanisms and Molecular Targets of Compound Danshen Dropping Pill for Heart Disease Caused by High Altitude Based on Network Pharmacology and Molecular Docking
por: Yan, Jiayi, et al.
Publicado: (2021)

Compound danshen dripping pills combined with trimetazidine in treating unstable angina pectoris: Protocol for a systematic review of randomized controlled trials
por: Yao, Dongfeng, et al.
Publicado: (2019)

Effectiveness and safety of Danshen injection on heart failure: Protocol for a systematic review and meta-analysis
por: Yuan, Tianhui, et al.
Publicado: (2019)

Protective effect of Guanxin Danshen formula on myocardial ischemiareperfusion injury in rats
por: Li, Lanfang, et al.
Publicado: (2023)

Optimal strategy of switching from clopidogrel to ticagrelor in Chinese acute coronary syndrome patients with complicated coronary artery disease: the switching from clopidogrel to ticagrelor (SHIFT-CACS) study
por: Yao, Ying, et al.
Publicado: (2019)

Corrigendum: Evaluation of herb–drug interaction between Danshen and rivaroxaban in rat and human liver microsomes
por: Wang, Xu, et al.
Publicado: (2022)

Clinical effect of Danshen decoction in patients with heart failure: A systematic review and meta-analysis of randomized controlled trials
por: Li, Ziyi, et al.
Publicado: (2023)

Efficacy and safety of rivaroxaban plus clopidogrel versus aspirin plus clopidogrel in patients with coronary atherosclerotic heart disease and gastrointestinal disease undergoing percutaneous coronary intervention: study protocol for a non-inferiority randomized controlled trial
por: Zhou, Tienan, et al.
Publicado: (2023)

Danshen Decoction in the Treatment of Hyperlipidemia: A Systematic Review and Meta-Analysis Protocol of Randomized Controlled Trials
por: Liu, Mengnan, et al.
Publicado: (2022)

Compound Danshen Dripping Pill Inhibits Retina Cell Apoptosis in Diabetic Rats
por: Zhang, Qian, et al.
Publicado: (2018)

Effects of switching ticagrelor to clopidogrel on cardiovascular outcomes in patients with acute coronary syndrome
por: Liu, Lin, et al.
Publicado: (2018)

Analysis of the Reactivity of Aspirin and Clopidogrel and Its Influencing Factors in Patients with Coronary Heart Disease at High Altitude
por: Chang, Rong, et al.
Publicado: (2021)

Neuron Regeneration and Proliferation Effects of Danshen and Tanshinone IIA
por: Shen, Jui-Lung, et al.
Publicado: (2011)

DsTRD: Danshen Transcriptional Resource Database
por: Shao, Yuxuan, et al.
Publicado: (2016)

Effects of Danshen tablets on pharmacokinetics of amlodipine in rats
por: Zhang, Haixia, et al.
Publicado: (2019)

Immunomodulatory Effects of Danshen (Salvia miltiorrhiza) in BALB/c Mice
por: Gao, Donghong, et al.
Publicado: (2012)

Effects of compound Danshen dropping pills on adverse cardiovascular events and quality of life after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis
por: Lv, Lina, et al.
Publicado: (2022)

Comparison of the effects of ticagrelor and clopidogrel on heart rate variability and heart rate turbulence in patients with percutaneous coronary interventions
por: Yagcioglu, Pinar, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bp8ua64u4n79dqjena6rrtbf3f